Marine Biologics completed the acquisition of Spoitz Enterprises.

Marine Biologics, a macroalgae innovator, completed the acquisition of Spoitz Enterprises, macroalgae biochemical engineering firm specializing in post-harvest technology and compositional data analysis. Financial terms were not disclosed. “Bringing together these talented teams enables us to solve critical bottlenecks in the macroalgae supply chain. The acquisition puts us on the path to making macroalgae the innovation workhorse for the bioeconomy,” Patrick Griffin, Marine Biologics CEO.